Fig. 3: Hepatitis B incidence rates with different immunization strategies and relative vaccine effectiveness of hepatitis B vaccine booster dose at different periods in Beijing.
From: Retrospective cohort study of hepatitis B immunization strategy effects in Beijing across 30 years
A hepatitis B incidence rate and relative vaccine effectiveness at 1 years, 5 years, 10 years, and 15 years after the booster dose. The numbers of hepatitis B virus (HBV) positive infections and total populations in the three groups of B1, B2 and C are presented in Supplementary Table 2. The upper limit of 95% confidence interval (CI) is presented for the incidence rate of hepatitis B. The vaccine effectiveness (VE) and 95% CI are presented. B vaccine effectiveness of hepatitis B vaccine booster dose at different periods. Group B1, the booster group; Group B2, the local control group; Group C, the national control group. The detailed numbers of hepatitis B and total population are presented in Supplementary Table 3. The relative VE and 95% CI are presented.
